Advertisement
Screener

Actuate Therapeutics, Inc. (ACTU) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number

2.8 / 5 stars · 68/120 Roast Me

Actuate Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number

Actuate Therapeutics, Inc. (ACTU) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 589.82 thousand shares as of 2025-12-31, per its 10-K filed 2026-03-26.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2026-03-26

  • 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 589.82K shares.
  • 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 189.70K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
2025-12-31589.82K shares
10-K · filed 2026-03-26
2024-12-31189.70K shares
10-K · filed 2025-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
Korsana Biosciences, Inc. (CYCN)United States$0.016B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B